All Articles Tagged With: "Actavis"
Articles
Kapidex Medication Errors Spark Name Change
The FDA has approved a name change for the heartburn drug Kapidex, after receiving reports of pharmacists confusing it with other drugs.
Digitek Trial in Federal MDL Scheduled to Begin January 2011
A federal judge presiding over the consolidated Digitek litigation, which is centralized in the U.S. District Court for the Southern District of West Virginia, has scheduled the first trial over the recalled heart drug to being in January 2011.
Generic Reglan Tardive Dyskinesia Lawsuit Not Preempted: Appeals Court
The U.S. Court of Appeals for the Firth Circuit has rejected the argument by a generic drug maker that federal law preempts a state-law failure-to-warn claim filed by a user of their generic Reglan, who developed the rare movement disorder tardive dyskinesia.
Digitek Lawsuits Selected for First Trials in Federal MDL
Five Digitek overdose lawsuits have been selected to serve as “bellwether” cases that will lead the way for hundreds of cases filed against Actavis Totowa and distributors of their generic heart drug over deaths and other injuries allegedly caused by oversized pills that were recalled in April 2008.
Generic Adderall Recall: Oversized Barr Dextroamphetamine/Amphetamine
The FDA and Barr Laboratories, Inc. have announced a recall for generic Adderall tablets that may contain more of the active pharmaceutical ingredients than they are supposed to have, posing a risk of serious side effects among users of the ADHD drug.
Phenobarbital Recall in Canada Due to Oversized Tablets
Health Canada has issued a pms-Phenobarbital recall for 60 milligram tablets of the anxiety and seizure drug distributed by Pharmascience Inc., due to the possibility of that some tablets may be oversized. Receiving too much of the active medication could cause serious physical injury from overdose, such as coma or cardiac arrest.
Recalled Digoxin Manufacturer Raided by US Marshalls and FDA
At the request of the FDA, U.S. Marshals raided generic drug manufacturer Caraco Pharmaceutical Laboratories, Ltd., shutting down manufacturing and seizing inventory. The action came after FDA inspections found that the drug maker was continuing to fail to meet federal safety and health requirements.
Reglan (Metoclopramide) Lawsuit Consolidation Being Considered Today
The U.S. Judicial Panel on Multidistrict Litigation is scheduled to hear oral arguments today about whether to consolidate all lawsuits involving Reglan and generic metoclopramide drugs, which have been linked to an increased risk of a serious movement disorder known as tardive dyskinesia.
Actavis Digitek Recall Has Resulted in 130 Lawsuits Consolidated in MDL
An additional 23 Digitek lawsuits filed against Actavis Totowa and their distributors in various federal district courts throughout the United States, have been transferred to the U.S. District Court for the Western District of Virginia, where they will be consolidated with at least 107 other cases that are being coordinated during pretrial proceedings as part [...]
Digoxin Drug Recall Issued by AS Medications Solutions
On May 11, 2009, the FDA posted notice of a digoxin drug recall issued by A S Medication Solutions, LLC, a drug repackaging company who distributed .25mg tablets manufactured by Caraco Pharmaceutical Laboratories, Ltd. The tablets could contain too much or too little of the drug, potentially increasing the risk of digoxin toxicity. [...]
